200 related articles for article (PubMed ID: 8622006)
1. Tamoxifen-associated eye disease. A review.
Nayfield SG; Gorin MB
J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxicity in low-dose tamoxifen: a prospective study.
Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
[TBL] [Abstract][Full Text] [Related]
3. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
4. Retinal changes associated with tamoxifen treatment for breast cancer.
Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and ocular toxicity.
Ah-Song R; Sasco AJ
Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen retinopathy: does it really exist?
Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
[TBL] [Abstract][Full Text] [Related]
7. Long-term tamoxifen citrate use and potential ocular toxicity.
Gorin MB; Day R; Costantino JP; Fisher B; Redmond CK; Wickerham L; Gomolin JE; Margolese RG; Mathen MK; Bowman DM; Kaufman DI; Dimitrov NV; Singerman LJ; Bornstein R; Wolmark N
Am J Ophthalmol; 1998 Apr; 125(4):493-501. PubMed ID: 9559735
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-induced ocular toxicity.
Mihm LM; Barton TL
Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
[No Abstract] [Full Text] [Related]
9. [Ocular toxicity caused by tamoxifen: case report].
Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
Arq Bras Oftalmol; 2005; 68(4):554-6. PubMed ID: 16322846
[TBL] [Abstract][Full Text] [Related]
10. Pseudocystic foveal cavitation in tamoxifen retinopathy.
Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
[TBL] [Abstract][Full Text] [Related]
11. Screening for tamoxifen ocular toxicity: a prospective study.
Therssen R; Jansen E; Leys A; Rutten J; Meyskens J
Eur J Ophthalmol; 1995; 5(4):230-4. PubMed ID: 8963159
[TBL] [Abstract][Full Text] [Related]
12. Crystalline maculopathy: a rare complication of tamoxifen therapy.
Srikantia N; Mukesh S; Krishnaswamy M
J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
[TBL] [Abstract][Full Text] [Related]
13. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Bourla DH; Sarraf D; Schwartz SD
Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
[TBL] [Abstract][Full Text] [Related]
14. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ
Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223
[TBL] [Abstract][Full Text] [Related]
15. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
Salomão SR; Watanabe SE; Berezovsky A; Motono M
Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
[TBL] [Abstract][Full Text] [Related]
16. Ocular adverse reactions to tamoxifen--a review.
Dulley P
Ophthalmic Physiol Opt; 1999 Mar; 19 Suppl 1():S2-9. PubMed ID: 10645394
[No Abstract] [Full Text] [Related]
17. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
[TBL] [Abstract][Full Text] [Related]
18. Eye problems in breast cancer patients treated with tamoxifen.
Paganini-Hill A; Clark LJ
Breast Cancer Res Treat; 2000 Mar; 60(2):167-72. PubMed ID: 10845279
[TBL] [Abstract][Full Text] [Related]
19. [Unusual symptoms for tamoxifen-associated maculopathy].
Hager T; Hoffmann S; Seitz B
Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
[TBL] [Abstract][Full Text] [Related]
20. Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
Andreanos K; Oikonomakis K; Droutsas K; Petrelli M; Kymionis G
Cornea; 2017 Mar; 36(3):377-378. PubMed ID: 27918356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]